John W Park

Title: John W Park: Innovator in Immunoliposome Technology

Introduction

John W Park is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of immunoliposome technology, holding a total of 5 patents. His work focuses on optimizing drug delivery systems that target specific cells, which has important implications for medical treatments.

Latest Patents

One of John W Park's latest patents involves the development of immunoliposomes that optimize the internalization of drugs into target cells. This invention provides a novel approach to drug delivery by utilizing an Fab' domain of an antibody that specifically binds to a characteristic cell surface marker. The immunoliposomes are composed of an amphipathic vesicle-forming lipid and a polyethylene glycol derivatized lipid. Additionally, the invention includes growth-inhibiting immunoliposomes that can inhibit the growth and proliferation of target cells without the need for growth-inhibiting therapeutic agents.

Career Highlights

Throughout his career, John W Park has worked with prestigious institutions, including the University of California. His innovative research has led to advancements in the field of drug delivery systems, making him a key figure in this area of study.

Collaborations

John has collaborated with notable professionals in his field, including Christopher C Benz and Keelung Hong. These collaborations have further enhanced his research and contributions to immunoliposome technology.

Conclusion

John W Park is a distinguished inventor whose work in immunoliposome technology has the potential to revolutionize drug delivery systems. His innovative patents and collaborations highlight his commitment to advancing medical science.